← Leaderboards
Richard John Brennan
Genego, Inc.
$411,226
Attributed
$411,226
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $262.9K · FY2009–10$500K$375K$250K$125K$0
'09
'10
Funding mix
By agency
NIH$411,226 · 2
By mechanism
R43$411,226 · 2
Top collaborators
No co-investigators on record.
Most similar at Genego, Inc.
Same institution · by research overlap
- Sean Ekins$25,563,910
- Tatiana A Nikolskaya$1,927,369
Others in their field
Top investigators on “Peer Review”
- David R. Weir · University Of Michigan At Ann Arbor$297,350,290
- Pavel Kabat · Internationales Institut Fur Angewandte Systemanalyse$139,962,704
- Norman Wolmark · Nsabp Foundation, Inc.$96,425,786
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Hugh Rosen · Scripps Research Institute$78,578,624
- Michael S. Saag · University Of Alabama At Birmingham$73,885,969
Research focus
Peer ReviewReportingLiteraturePathway InteractionsPharmacologyProteinsImageryInterestMetabolicPathway AnalysisPharmacologic SubstanceBiologicalGene ExpressionPhysiciansComputer SoftwareData SetDatabasesData AnalysesMapsMarketingMetabolomicsOntologyGenesResearch Design
Grant awards (3)
An integrated systems pharmacology platform for pharmacogenomic research$143,710
R43 · FY2010 · GM · contact PI
A Systems Biology Platform for the Assessment of Substance Abuse$119,166
R43 · FY2010 · DA · contact PI
An integrated systems pharmacology platform for pharmacogenomic research$148,350
R43 · FY2009 · GM · contact PI